Barely Significant
← all excerpts

Developing transcriptomic biomarkers for TAVO412 utilizing next generation sequencing analyses of preclinical tumor models.

Front Immunol · 2025 · PMC11847686 · PMID 39995668

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Interestingly, c-Met, one of the targets of TAVO412, which was supposed to be a positive predictor, showed a trend of negatively predicting the response, although the association between gene expression and eGR ratio was not significant ( Figure 3D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.